logologo
QuantliQuantli

Cytokinetics Inc

CYTK

NASDAQ

Biotechnology

$74.13

USD

+0.68 (+0.93%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $10.36B

Volume 1.8M

Price Target

$99.00$118.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $118.00 and a min estimate of $99.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$108.50

+$7.0 vs prior

Implied Upside

+46.4%

+9.4% vs prior

Analyst Covering

4

-8 vs prior period

Consensus

Buy

Improved vs prior

Signal Quality

Consensus Freshness

25%

Many ratings are older - consensus may be less current

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

4 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Ashwani Verma

UBS

Buy

Upgraded

1 month ago

Plus
Plus
Plus

Salim Syed

Mizuho

Buy

Maintained

1 month ago

Plus
Plus
Plus

Serge Belanger

Needham

Buy

Reiterated

2 months ago

Plus
Plus
Plus

Eric Joseph

JP Morgan

Buy

Initiated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

SMMT

Summit Therapeutics Inc

$13.35

-4.6%

KRYS

Krystal Biotech Inc

$332.27

+1.2%

APGE

Apogee Therapeutics Inc

$134.55

+0.1%

ARWR

Arrowhead Pharmaceuticals Inc

$86.64

+1.2%

PRAX

Praxis Precision Medicines Inc

$366.81

-0.5%

PTGX

Protagonist Therapeutics Inc

$155.10

+2.4%

KYMR

Kymera Therapeutics Inc

$117.39

+2.6%

MDGL

Madrigal Pharmaceuticals Inc

$507.56

+0.0%

HALO

Halozyme Therapeutics Inc

$98.66

-2.0%